Boehringer Ingelheim (Philippines), Inc. expands its Stop Rabies program with a mass vaccination drive at The Clubhouse in Filinvest 2, Quezon City to mark Rabies Awareness Month. The initiative provided free pet vaccinations, reinforcing the importance of responsible pet ownership and strengthening community-wide rabies prevention efforts. With support from the Bureau of Animal Industry and Magic 89.9 FM’s Pets in the City radio program, veterinarians and volunteers worked together to educate pet owners on the crucial role of vaccination in eliminating rabies and safeguarding public health.

Through this vaccination drive, Boehringer Ingelheim remains committed to making vaccinations accessible and building safer, rabies-free communities in the Philippines. For more information about Boehringer Ingelheim’s rabies prevention initiatives, visit https://www.boehringer-ingelheim.com/animal-health.
Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com

Boehringer Ingelheim – Animal Health business
Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society.
Learn more at www.boehringer-ingelheim.com